{"title":"疼痛性非骨转移肿瘤的姑息性放疗。","authors":"Tetsuo Saito","doi":"10.1007/s10147-025-02803-4","DOIUrl":null,"url":null,"abstract":"<p><p>As suggested by the findings of our previous investigations, palliative radiotherapy for painful lesions other than bone metastases may be as commonly used in clinical settings as it is for painful bone metastases (PBMs). Given the substantial number of patients requiring radiotherapy for painful non-bone-metastasis tumors (PNTs), the absence of specific clinical guidelines for this subset of patients poses a significant issue. This review aims to explore the effectiveness of palliative radiotherapy for PNTs and compare it to the well-established evidence supporting its use for PBMs. Additionally, the review discusses the optimal dose-fractionation schedules in palliative radiotherapy for the management of PNTs.</p>","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":"1500-1504"},"PeriodicalIF":2.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Palliative radiotherapy for painful non-bone-metastasis tumors.\",\"authors\":\"Tetsuo Saito\",\"doi\":\"10.1007/s10147-025-02803-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As suggested by the findings of our previous investigations, palliative radiotherapy for painful lesions other than bone metastases may be as commonly used in clinical settings as it is for painful bone metastases (PBMs). Given the substantial number of patients requiring radiotherapy for painful non-bone-metastasis tumors (PNTs), the absence of specific clinical guidelines for this subset of patients poses a significant issue. This review aims to explore the effectiveness of palliative radiotherapy for PNTs and compare it to the well-established evidence supporting its use for PBMs. Additionally, the review discusses the optimal dose-fractionation schedules in palliative radiotherapy for the management of PNTs.</p>\",\"PeriodicalId\":13869,\"journal\":{\"name\":\"International Journal of Clinical Oncology\",\"volume\":\" \",\"pages\":\"1500-1504\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10147-025-02803-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-025-02803-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
Palliative radiotherapy for painful non-bone-metastasis tumors.
As suggested by the findings of our previous investigations, palliative radiotherapy for painful lesions other than bone metastases may be as commonly used in clinical settings as it is for painful bone metastases (PBMs). Given the substantial number of patients requiring radiotherapy for painful non-bone-metastasis tumors (PNTs), the absence of specific clinical guidelines for this subset of patients poses a significant issue. This review aims to explore the effectiveness of palliative radiotherapy for PNTs and compare it to the well-established evidence supporting its use for PBMs. Additionally, the review discusses the optimal dose-fractionation schedules in palliative radiotherapy for the management of PNTs.
期刊介绍:
The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.